ArticleOncoTargets and therapy2020

MiR-138 Suppresses the PDK1 Expression to Decrease the Oxaliplatin Resistance of Colorectal Cancer.

Yao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.